At the time of writing, MBX Biosciences Inc [MBX] stock is trading at $36.31, down -0.44%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The MBX shares have gain 26.52% over the last week, with a monthly amount glided 27.72%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
MBX Biosciences Inc [NASDAQ: MBX] stock has seen the most recent analyst activity on December 04, 2025, when Goldman initiated its Sell rating and assigned the stock a price target of $18. On October 15, 2025, Truist initiated with a Buy rating and assigned a price target of $50 on the stock. Mizuho initiated its recommendation with an Outperform and recommended $38 as its price target on August 05, 2025. Oppenheimer started tracking with an Outperform rating for this stock on July 16, 2025, and assigned it a price target of $38. In a note dated April 10, 2025, Citizens JMP initiated an Mkt Outperform rating and provided a target price of $38 on this stock.
For the past year, the stock price of MBX Biosciences Inc fluctuated between $4.81 and $36.49. Currently, Wall Street analysts expect the stock to reach $41.5 within the next 12 months. MBX Biosciences Inc [NASDAQ: MBX] shares were valued at $36.31 at the most recent close of the market. An investor can expect a potential return of 14.29% based on the average MBX price forecast.
Analyzing the MBX fundamentals
Gross Profit Margin for this corporation currently stands at -0.3% with Operating Profit Margin at -409.32%, Pretax Profit Margin comes in at -362.59%, and Net Profit Margin reading is -362.59%. To continue investigating profitability, this company’s Return on Assets is posted at -0.2, Equity is -0.29 and Total Capital is -0.23. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It is important to note that MBX Biosciences Inc [NASDAQ:MBX] has a current ratio of 32.95. Further, the Quick Ratio stands at 32.95, while the Cash Ratio is 18.5.
Transactions by insiders
Recent insider trading involved CORNELIUS JAMES M, Former Director, that happened on Jan 12 ’26 when 30864.0 shares were purchased. President & CEO, Hawryluk P. Kent completed a deal on Oct 20 ’25 to buy 20000.0 shares. Meanwhile, Director Hoerter Steven L. bought 20000.0 shares on Oct 17 ’25.
